
Researchers target ferroptosis resistance of cancer cells
In Nature, Sebastian Doll from Marcus Conrad's group at Helmholtz Center Munich and the group of José Pedro Friedmann Angel at University Würzburg,...

AMR: GARDP and Entasis Therapeutics start pivotal study
In the open-label study enroling 1,000 patients, safety and efficacy of zoliflodacin will be compared with a combination of azithromycin and...

Test detects breast cancer in earliest stage
The new research results were presented at the 2019 NCRI Cancer Conference today by Daniyah Alfattani from National Cancer Research Institute (NCRI)...

Boehringer and Zealand to advance obesity drug
Boehringer is collaborating with Danish Zealand Pharma on a long-acting amylin analogue (BI 473494) and a GLP-1/glucagon dual-acting agonist (BI...

Meatable NV raises US$10m in seed funding
BlueYard Capital, the Eurostars Programme of the European Commission, and angel VCs Taavet Hinrikus and Albert Wenger (Union Square Ventures)...

Sherlock Bioscience and Mologic enter partnership
Mologic said it will invest a part of an expansion to its $4.9m grant from the Bill and Melinda-Gates Foundation to finance access to Sherlock's...

Abcam buys Expedeon’s immunology business
“This purchase price is equivalent to twice Expedeon’s current market capitalisation or excess of 9-times 2018 annual group revenue,” the company...